[Asymmetric dimethil-arginine (ADMA) as a link between insulin resistance and atherosclerosis].
Debreceni Egyetem, Orvos- és Egészségtudományi Centrum, Neurológiai Klinika, Debrecen.
Judit
J
Zsuga
D000328:Adult; D001120:Arginine / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology; D050197:Atherosclerosis / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000378:metabolism; D016893:Carotid Stenosis / Q000000981:diagnostic imaging / Q000201:enzymology / Q000378:metabolism* / Q000473:pathology; D002845:Chromatography; D004791:Enzyme Inhibitors / Q000378:metabolism* / Q000494:pharmacology; D005260:Female; D006710:Homocysteine / Q000378:metabolism; D006801:Humans; D007333:Insulin Resistance; D016014:Linear Models; D008297:Male; D008875:Middle Aged; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D052247:Nitric Oxide Synthase Type II / Q000378:metabolism; D012307:Risk Factors; D017539:Tunica Intima / Q000473:pathology; D017540:Tunica Media / Q000473:pathology; D018615:Ultrasonography, Doppler, Color
D004791:Enzyme Inhibitors; D006710:Homocysteine; C018524:N,N-dimethylarginine; D001120:Arginine; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II